Long‐term incubation with IL‐4 and IL‐10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor

No abstract is available for this paper.

• Publication year

  2005

• Venue

  British Journal of Haematology

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.2005.05783.xPMID 16225656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor-1 inhibits tissue factor activity

  2003cited by this paper
• Interleukin-4 ( IL-4 ) Inhibits Secretion of IL-lfl , Tumor Necrosis Factor a , and IL-6 by Human Monocytes

  2003cited by this paper
• Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1.

  2001influential reference
• Separation of dendritic cells from highly purified human monocytes by counterflow centrifugation induces tissue factor expression

  2000cited by this paper
• Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels.

  2000cited by this paper
• Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor.

  2000influential reference
• Protective role of interleukin-10 in atherosclerosis.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Down-regulation of Monocyte Tissue Factor Mediated by Tissue Factor Pathway Inhibitor and the Low Density Lipoprotein Receptor-related Protein*

  1999cited by this paper
• A role for interleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells.

  1998cited by this paper
• A role for interleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells

  1998cited by this paper
• Regulation of the uPAR/uPA system expressed on monocytes by the deactivating cytokines, IL‐4, IL‐10 and IL‐13: consequences on cell adhesion to vitronectin and fibrinogen

  1998cited by this paper
• IL‐10 inhibits LPS‐induced human monocyte tissue factor expression in whole blood

  1998cited by this paper
• The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines.

  1997cited by this paper
• Tissue factor expression on macrophages in coronary plaques in patients with unstable angina.

  1997cited by this paper
• Mechanism of tissue factor activation on HL-60 cells.

  1997cited by this paper
• Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor- dependent coagulation pathway

  1996cited by this paper
• Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

  1996cited by this paper
• Inhibition of tissue factor surface expression in human peripheral blood monocytes exposed to cytokines

  1996cited by this paper
• DOWN‐REGULATION OF FIBRINOGEN BIOSYNTHESIS BY IL‐4, IL‐10 AND IL‐13

  1996cited by this paper
• IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells.

  1995cited by this paper
• Structures and Functions of Multiligand and Lipoprotein Receptors

  1994cited by this paper
• The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor.

  1994cited by this paper
• Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina.

  1994cited by this paper
• Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation

  1994cited by this paper
• Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).

  1994cited by this paper
• Interleukin‐10 inhibits endotoxin‐induced tissue factor mRNA production by human monocytes

  1993cited by this paper
• IL‐4 and IL‐13 exhibit comparable abilities to reduce pyrogen‐induced expression of procoagulant activity in endothelial cells and monocytes

  1993cited by this paper
• IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.

  1992cited by this paper
• Inhibition of human monocyte adhesion by interleukin-4.

  1991cited by this paper
• Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.

  1990cited by this paper
• Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes.

  1990cited by this paper
• Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

  1989cited by this paper
• Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

  1989cited by this paper
• Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.

  1988cited by this paper
• Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor.

  1988cited by this paper
• Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor

  1988cited by this paper
• Endotoxin-induced procoagulant activity in equine peripheral blood monocytes.

  1988cited by this paper
• Endotoxin-induced procoagulant activity in equine peripheral blood monocytes.

  1988cited by this paper
• Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles.

  1987cited by this paper
• Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine.

  1986cited by this paper

• The natural reticular hematoma scaffold modulating inflammatory microenvironment and promoting bone regeneration

  2025cites this paper
• Impact of tissue factor expression and administration routes on thrombosis development induced by mesenchymal stem/stromal cell infusions: re-evaluating the dogma

  2024cites this paper
• Presence of procoagulant peripheral blood mononuclear cells in severe COVID-19 patients relate to ventilation perfusion mismatch and precede pulmonary embolism.

  2023cites this paper
• The interplay between hemostasis and immune response in biomaterial development for osteogenesis

  2022cites this paper
• G-Trap Assay II: Characterization of blood Leukocyte Functionality differentiates immune activation and immune suppression in bacteremia patient samples

  2022cites this paper
• Anti-inflammatory Activity of the Protein Z-Dependent Protease Inhibitor

  2021cites this paper
• An expanded analysis framework for multivariate GWAS connects inflammatory biomarkers to functional variants and disease

  2019cites this paper
• Regulation of monocyte anti-thrombotic gene and protein expression through platelet-derived material

  2016cites this paper
• Critical limb ischemia: thrombogenic evaluation of two autologous cell therapy products and biologic profile in treated patients

  2015cites this paper
• Comparative study of the effect of rivaroxaban and fondaparinux on monocyte’s coagulant activity and cytokine release

  2014cites this paper
• Interleukin-10 inhibits lipopolysaccharide-induced upregulation of tissue factor in canine peripheral blood monocytes.

  2012cites this paper
• Fibrin- and Collagen-Based Matrices Attenuate Inflammatory and Procoagulant Responses in Human Endothelial Cell Cultures Exposed to Staphylococcus aureus

  2011cites this paper
• The −589C>T polymorphism in the interleukin‐4 gene (IL‐4) is associated with a reduced risk of myocardial infarction in young individuals

  2008cites this paper
• IL-4 modulates tissue factor expression by human B lymphocytes in response to phorbol myristate acetate

  2006cites this paper